SUNITINIB ZENTIVA

Capsule, hard, 12.5mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength12.5mg
PackagingUkupno 28 kapsula tvrdih u blisteru (4x7) u kartonskoj kutiji
ManufacturerRemedica Ltd., Cyprus
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holderZENTIVA PHARMA DOO - DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJuly 17, 2023

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register